Stock OXIS INTERNATIONAL
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Oxis International Euronext Paris

Equities

US6918294025

End-of-day quote Euronext Paris
Other stock markets
- EUR - Intraday chart for Oxis International
26/03 GT Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
01/02 GT Biopharma to Conduct 1-for-30 Reverse Stock Split; Shares Fall MT

Chart calendar Oxis International

bc7172b5c833ee97dba428077cbd4aae.X0Gm_v68FnTqDWNORfowFIZ5riTztl8EXn5lgnte9cc.Ngfnh5TmJQKFSi92dp5JW8ss10rD2ztgKDwD0REOtvU-MJavsoknBIhFMg~45fb93239f5bff4a8d88b1cbab3b4f6d

Upcoming events on Oxis International

13/05/2024 Q1 2024 Earnings Release (Projected)
07/08/2024 Q2 2024 Earnings Release (Projected)
29/10/2024 Q3 2024 Earnings Release (Projected)

Past events on Oxis International

19/12/2023 12:30 am Extraordinary Shareholders Meeting
05/11/2023 07:30 am Society for Immunotherapy of Cancer Meeting - Abstract No:1180
05/11/2023 12:25 am Society for Immunotherapy of Cancer Meeting - Abstract No:1180
01/11/2023 06:30 pm Q3 2023 Earnings Release
18/08/2023 01:00 am H.C. Wainwright Immune Cell Engager Conference
07/08/2023 06:30 pm Q2 2023 Earnings Release
28/06/2023 11:30 pm Annual General Meeting
25/05/2023 ASTCT EBMT Joint Basic and Translational Scientific Meeting
16/05/2023 06:30 pm PEGS Boston Conference
16/05/2023 02:30 am Q1 2023 Earnings Release
31/03/2023 02:30 am Q4 2022 Earnings Release
28/02/2023 07:30 pm H.C. Wainwright Cell Therapy Virtual Conference
13/12/2022 04:30 am American Society of Hematology Meeting - Abstract Number: 4623
11/11/2022 07:30 pm Society for Immunotherapy of Cancer Meeting - Abstract Number: 1204
11/11/2022 07:30 pm Society for Immunotherapy of Cancer Meeting - Abstract Number: 1202
01/11/2022 02:45 am Q3 2022 Earnings Release
27/10/2022 05:00 am LD Micro Main Event Conference
10/10/2022 11:30 pm Extraordinary Shareholders Meeting
28/09/2022 Extraordinary Shareholders Meeting
13/09/2022 08:00 pm H.C. Wainwright Global Investment Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		0,00


-6,76
-6,10
-10.89%		-57,5
-46,2
-24.59%		-21,3
-21,2
-0.2%		-13,6
-13,9
2.65%
-17,4

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


-28,3
-16,9
-67.12%		-58,0
-46,6
-24.61%		-20,9
-21,5
2.87%		-7,60
-8,17
7.04%
-17,4

Net income
Million USD		Released
Forecast
Spread 		-38,6


-28,3
-16,9
-67.12%		-58,0
-46,3
-25.2%		-20,9
-21,5
3%		-7,60
-8,17
7.04%
-17,4

EPS
USD		Released
Forecast
Spread 		-342


-194
-6,75
-2766.67%		-61,8
-49,4
-25.1%		-19,8
-20,1
1.49%		-5,64
-6,00
6%
-10,8

Announcement Date27/03/2016/04/2128/03/2230/03/2326/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-18,2
-6,84
-165.6%		-5,44
-7,45
26.95%		-3,01
-5,96
49.4%		-7,02
-3,83
-83.15%		-5,78
-5,73
-0.93%		-3,67
-5,70
35.7%		-3,62
-4,15
12.75%		-3,12
-3,95
20.96%		-3,17
-3,54
10.43%
-3,88


-4,21


-4,52


-4,81

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-18,0
-6,56
-174.68%		-5,44
-7,33
25.82%		-2,98
-5,93
49.76%		-6,88
-3,77
-82.4%		-5,58
-6,23
10.35%		-0,23
-6,00
96.22%		-1,99
-4,10
51.41%		-2,42
-3,95
38.84%		-2,96
-3,54
16.26%
-3,88


-4,21


-4,52


-4,81

Net income
Million USD		Released
Forecast
Spread 		-18,0
-6,73
-167.95%		-5,44
-7,33
25.82%		-2,98
-5,93
49.76%		-6,88
-3,77
-82.4%		-5,58
-6,23
10.35%		-0,23
-6,00
96.22%		-1,99
-4,10
51.41%		-2,42
-3,95
38.84%		-2,96
-3,54
16.26%
-3,88


-4,21


-4,52


-4,81

EPS
USD		Released
Forecast
Spread 		-15,6
-6,20
-151.61%		-5,10
-6,90
26.09%		-3,00
-5,40
44.44%		-6,60
-3,30
-100%		-5,40
-5,70
5.26%		-0,30
-4,80
93.75%		-1,50
-3,00
50%		-1,80
-3,00
40%		-5,52
-2,70
-104.44%
-2,70


-2,70


-2,70


-3,00

Announcement Date28/03/2216/05/2215/08/2231/10/2230/03/2315/05/2307/08/2301/11/2326/03/24----

Upcoming sector events for Oxis International

Today 04:20 pm ANI PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
13/05/2024 PHARMANUTRA S.P.A.: Q1 2024 Earnings Release
13/05/2024 AARTI PHARMALABS LIMITED: Q4 2024 Earnings Release
13/05/2024 SHIONOGI & CO., LTD.: Q4 2023 Earnings Release
13/05/2024 MOCHIDA PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
13/05/2024 SAWAI GROUP HOLDINGS CO., LTD.: Q4 2023 Earnings Release
13/05/2024 MEGA LIFESCIENCES: Q1 2024 Earnings Release
13/05/2024 ALMIRALL, S.A.: Q1 2024 Earnings Release
13/05/2024 JW PHARMACEUTICAL CORPORATION: Q1 2024 Earnings Release (Projected)
13/05/2024 DONGKOOK PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Oxis International

Today PIRAMAL PHARMA LIMITED: Q4 2024 Earnings Release
Today NEULAND LABORATORIES LIMITED: Q4 2024 Earnings Release
Today NIPPON SHINYAKU CO., LTD.: Q4 2023 Earnings Release
Today ROHTO PHARMACEUTICAL CO.,LTD.: Q4 2023 Earnings Release (Projected)
Today KYORIN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
Today JCR PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
Today TTY BIOPHARM COMPANY LIMITED: Q1 2024 Earnings Release (Projected)
09/05/2024 SNDL INC.: Q1 2024 Earnings Release
09/05/2024 ALEMBIC PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
09/05/2024 COLLEGIUM PHARMACEUTICAL, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. GTBP Stock
  4. Stock
  5. Calendar Oxis International
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW